本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Emergent Biosolutions

6.99
-0.1200-1.69%
盘后6.97-0.0247-0.35%16:59 EDT
成交量:91.74万
成交额:645.04万
市值:3.79亿
市盈率:-2.84
高:7.29
开:7.20
低:6.88
收:7.11
数据加载中...
2024/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/29

重要事件披露

Form 8-K - Current report
2024/05/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/01

重要事件披露

Form 8-K - Current report
2024/05/01

重要事件披露

Form 8-K - Current report
2024/04/30

重要事件披露

Form 8-K - Current report
2024/04/26

重要事件披露

Form 8-K - Current report
2024/03/08

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/06

重要事件披露

Form 8-K - Current report
2024/02/21

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/18

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/11

重要事件披露

Form 8-K - Current report
2024/01/09

重要事件披露

Form 8-K - Current report
2023/12/13

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/12/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/12/11

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/11/28

重要事件披露

Form 8-K - Current report